Analyst Price Target is $6.50
▲ +238.54% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Enveric Biosciences in the last 3 months. The average price target is $6.50, with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 238.54% upside from the last price of $1.92.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Enveric Biosciences.